Document is current
Any future updates will be listed below
-
Authors
Danieli, Maria
Barretta, Francesco
Fiore, Marco
Radaelli, Stefano
Sangalli, Claudia
Barisella, Marta
Stacchiotti, Silvia
Palassini, Elena
Miceli, Rosalba
Callegaro, Dario
Casali, Paolo Giovanni
Gronchi, Alessandro https://orcid.org/0000-0002-4703-3534
- License Information
-
More Information
Article History
Received: 31 July 2020
Accepted: 21 December 2020
First Online: 28 January 2021
Disclosures
: Paolo Casali: In the past years, I have had honoraria for speaker, consultancy, or advisory role from: Bayer, Deciphera, Eisai, Eli Lilly, Pfizer. At my institution, my Unit received funds from: Advenchen Laboratories, Amgen Dompé, AROG Pharmaceuticals, Bayer, Blueprint Medicines, Daiichi Sankyo, Deciphera, Eisai, Eli Lilly, Epizyme Inc, Glaxo, Karyopharm Pharmaceuticals, Novartis, Pfizer, PharmaMar. The other authors do not have any commercial interest in the subject of study and no funding was received in support of this work.
